Predict your next investment

CelgenTek Innovations Corp company logo
HEALTHCARE | Medical Devices & Equipment
celgentek.com

See what CB Insights has to offer

Stage

Unattributed | Alive

Total Raised

$2M

Last Raised

$2M | 6 yrs ago

About CelgenTek Innovations Corp

CelgenTek Innovations Corporation is an Orthobiologics Implant Company incorporating technologies from Innovision, a Memphis TN company and CelgenTek, an Irish (Shannon) based medical device company. CelgenTek Innovations recently launched its N-Force technology and iN3 Cement (Structured Orthobiologic Matrix, SOM) in Europe and is currently preparing for its U.S. launch.

CelgenTek Innovations Corp Headquarter Location

1975 Nonconnah Blvd

Memphis, Tennessee, 38132,

United States

901-233-9101

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing CelgenTek Innovations Corp

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

CelgenTek Innovations Corp is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

7,867 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

CelgenTek Innovations Corp Patents

CelgenTek Innovations Corp has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/15/2016

Application

Application Date

4/15/2016

Grant Date

Title

Related Topics

Status

Application

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.